AU1479600A - Anti-icam-r antibody-induced apoptosis - Google Patents

Anti-icam-r antibody-induced apoptosis

Info

Publication number
AU1479600A
AU1479600A AU14796/00A AU1479600A AU1479600A AU 1479600 A AU1479600 A AU 1479600A AU 14796/00 A AU14796/00 A AU 14796/00A AU 1479600 A AU1479600 A AU 1479600A AU 1479600 A AU1479600 A AU 1479600A
Authority
AU
Australia
Prior art keywords
icam
antibody
induced apoptosis
apoptosis
induced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14796/00A
Inventor
Brenda Sandmaier
Anne Stucki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fred Hutchinson Cancer Center
Original Assignee
Fred Hutchinson Cancer Research Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fred Hutchinson Cancer Research Center filed Critical Fred Hutchinson Cancer Research Center
Publication of AU1479600A publication Critical patent/AU1479600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Radiation-Therapy Devices (AREA)
AU14796/00A 1998-11-17 1999-11-17 Anti-icam-r antibody-induced apoptosis Abandoned AU1479600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19354898A 1998-11-17 1998-11-17
US09193548 1998-11-17
PCT/US1999/027327 WO2000029020A1 (en) 1998-11-17 1999-11-17 Anti-icam-r antibody-induced apoptosis

Publications (1)

Publication Number Publication Date
AU1479600A true AU1479600A (en) 2000-06-05

Family

ID=22714080

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14796/00A Abandoned AU1479600A (en) 1998-11-17 1999-11-17 Anti-icam-r antibody-induced apoptosis

Country Status (5)

Country Link
EP (1) EP1131097A1 (en)
JP (1) JP2002529518A (en)
AU (1) AU1479600A (en)
CA (1) CA2349581A1 (en)
WO (1) WO2000029020A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1313327A (en) * 2000-03-15 2001-09-19 上海博德基因开发有限公司 Polypeptide-human junctional adhesion molecule 12 and polynucleotide for coding it
EP2075256A2 (en) 2002-01-14 2009-07-01 William Herman Multispecific binding molecules
GB201016864D0 (en) * 2010-10-06 2010-11-17 Univ Aston Therapeutic methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2132637A1 (en) * 1993-01-22 1994-08-04 Michael W. Gallatin Icam-related protein

Also Published As

Publication number Publication date
CA2349581A1 (en) 2000-05-25
WO2000029020A1 (en) 2000-05-25
EP1131097A1 (en) 2001-09-12
JP2002529518A (en) 2002-09-10

Similar Documents

Publication Publication Date Title
AU6007699A (en) Showerhead
AU3485999A (en) Neo-tryptophan
AU1424200A (en) Compounds
AU4501699A (en) Aminoazole compounds
AU4030399A (en) Bicyclic compounds having an anti-thrombitic effect
AU1434500A (en) Compounds
AU3437799A (en) City-car
AU3522399A (en) Carvedilol-galenics
AU3253699A (en) Myxochelines
AU5407599A (en) Sphingolipid-desaturase
AU2185199A (en) Apoptosis inducers
AU5516599A (en) Substituted 3-aryl-pyrazoles
AU8363398A (en) Capotasto
EP0938928A3 (en) Showers
AU5998199A (en) New bis-benzimidazoles
AU2609599A (en) Sensor-coupling
AU1479600A (en) Anti-icam-r antibody-induced apoptosis
AU4511499A (en) Substituted cyclooctadepsipeptides
AU5154399A (en) Scraper
AU3204999A (en) Futureball
AU2069199A (en) Codelets
AU4507899A (en) Substituted n-aryl-o-alkyl-carbamates
AU5223199A (en) Bathtub-bathseat
AU1055399A (en) Rollerboard
AU3347599A (en) Aeromobile

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase